Sharma et al27 investigated the association between PSA screening and the incidence of metastatic prostate cancer using state-level data from the North American Association of Central Cancer Registries from 1999 to 2017 and the Behavioral Risk Factor Surveillance System from 2001 to 2018. This evidence concerns the gene KLK3 and cancer.